Valve thrombosis and Degeneraon aBer Transcatheter Mitral...

1
. METHOD FOR VIR MATERIAL CONCLUSION VIR may be an op.on for selected pa.ents. Cau.on is to be taken according to an.coagula.on and valve thrombosis. S.ll we do not know the durability of the THV especially in the mitral posi.on RESULTS Valve thrombosis and DegeneraAon aBer Transcatheter Mitral Valve ImplantaAon (V-i-R) Gry Dahle MD, Kjell Arne Rein MD,PhD, JT Offstad MD;PhD, Arnt Fiane , MD,PhD Rikshospitalet, OUS, Oslo, Norway INTRODUCTION Valve-in-valve (VIV) and valve-in-ring (VIR) are established methods for degenerated bioprostheses and failed repairs. There are reports on thrombosis and degenera.on of transcatheter heart valves (THV) in na.ve valve posi.on. This can also be an issue for the VIV/R procedures. We report one valve thrombosis and one THV degenera.on in mitral VIR PaAent 1 PaAent 2 Valve thrombosis Follow upfollowint sc.lysis and three months of coumadine INR 3-3.5 Follow up at 5 years gradient of 16mmHg At 4 years follow up only gradient of 6mmHg Now highly symptoma.c Procedure of VIV planned PaAent 2 PaAent 1

Transcript of Valve thrombosis and Degeneraon aBer Transcatheter Mitral...

Page 1: Valve thrombosis and Degeneraon aBer Transcatheter Mitral ...eposterkiosk.com/mitral17/ePosters/201-Dahle.pdf · Switched back on NOAC three weeks before fu Still No dyspnoe Echo:

.

METHODFORVIR

MATERIAL

CONCLUSIONVIRmaybeanop.onforselectedpa.ents.Cau.onistobetakenaccordingtoan.coagula.onandvalvethrombosis.S.llwedonotknowthedurabilityoftheTHVespeciallyinthemitralposi.on

RESULTS

ValvethrombosisandDegeneraAonaBerTranscatheterMitralValveImplantaAon(V-i-R)

GryDahleMD,KjellArneReinMD,PhD,JTOffstadMD;PhD,ArntFiane,MD,PhDRikshospitalet,OUS,Oslo,Norway

INTRODUCTIONValve-in-valve(VIV)andvalve-in-ring(VIR)areestablishedmethodsfordegeneratedbioprosthesesandfailedrepairs.Therearereportsonthrombosisanddegenera.onoftranscatheterheartvalves(THV)inna.vevalveposi.on.ThiscanalsobeanissuefortheVIV/Rprocedures.WereportonevalvethrombosisandoneTHVdegenera.oninmitralVIR

PaAent1

PaAent2 Valvethrombosis

Followupfollowintsc.lysisandthreemonthsofcoumadineINR3-3.5

Followupat5yearsgradientof16mmHgAt4yearsfollowuponlygradientof6mmHgNowhighlysymptoma.cProcedureofVIVplanned

PaAent2PaAent1